Back to Search

MARK LEAHY, MD

MD

Obstetrics & Gynecology Physician

NPI: 1629043773Individual

Specialties, Licenses & Credentials

Obstetrics & Gynecology PhysicianPrimary

Obstetrics & Gynecology

Code: 207V00000X

19033(NE)

Research & Publications (20)

Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
PMID 17095209·Eur J Cancer·2007
3-trial
"What makes a good doctor?" A cross sectional survey of public opinion.
PMID 12674150·Ir Med J·2003
8-other
Train 'em and reap. A structured training program for front- and back-office staff.
PMID 11836866·MGMA Connex·2002
8-other
Therapeutic potential of Mdm2 inhibition in malignant germ cell tumours.
PMID 19560254·Eur Urol·2010
8-other
Factors associated with resistance to dementia despite high Alzheimer disease pathology.
PMID 19171833·Neurology·2009
4-observational
Technology use by rural and urban oldest old.
PMID 19478400·Technol Health Care·2009
8-other
"Cajoling" as a means of engagement in the dysphagia clinic.
PMID 19145549·Semin Speech Lang·2009
8-other
Correlates of dating violence among male and female heavy-drinking college students.
PMID 18981192·J Interpers Violence·2009
8-other
Exceptional brain aging in a rural population-based cohort.
PMID 19566620·J Rural Health·2009
8-other
Catastrophic bleeds during end-of-life care in haematology: controversies from Australian research.
PMID 18810505·Support Care Cancer·2009
8-other
Intimate partner violence and preschoolers' explicit memory functioning.
PMID 18540770·J Fam Psychol·2008
8-other
Comparison of results of total disc replacement in postdiscectomy patients versus patients with no previous lumbar surgery.
PMID 18580740·Spine (Phila Pa 1976)·2008
4-observational
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy.
PMID 18768781·Blood·2008
3-trial
Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab.
PMID 18522934·Ann Oncol·2008
4-observational
A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma.
PMID 18932253·Cancer·2008
3-trial
Judging stuttering in an unfamiliar language: the importance of closeness to the native language.
PMID 18092220·Clin Linguist Phon·2008
8-other
A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992).
PMID 18417462·Ann Oncol·2008
3-trial
Effect of cranberry juice concentrate on chemically-induced urinary bladder cancers.
PMID 18497966·Oncol Rep·2008
7-preclinical
Sub-epidermal imaging using polarized light spectroscopy for assessment of skin microcirculation.
PMID 17908201·Skin Res Technol·2007
8-other
Measurement of in vivo BCR-ABL kinase inhibition to monitor imatinib-induced target blockade and predict response in chronic myeloid leukemia.
PMID 17906206·J Clin Oncol·2007
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
700 E 29TH ST
FREMONT, NE 68025

Location

Practice Location

700 E 29TH ST, FREMONT, NE
(402) 721-3133

Quick Facts

NPI
1629043773
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile